Matthew M. Roden, Ph.D. - Publications
Affiliations: | 2004 | Yeshiva University, New York, NY, United States |
Area:
ImmunologyYear | Citation | Score | |||
---|---|---|---|---|---|
2006 | Roden MM, Brims DR, Fedorov AA, DiLorenzo TP, Almo SC, Nathenson SG. Structural analysis of H2-Db class I molecules containing two different allelic forms of the type 1 diabetes susceptibility factor beta-2 microglobulin: implications for the mechanism underlying variations in antigen presentation. Molecular Immunology. 43: 1370-8. PMID 16229893 DOI: 10.1016/J.Molimm.2005.08.005 | 0.43 | |||
2002 | Ostrov DA, Roden MM, Shi W, Palmieri E, Christianson GJ, Mendoza L, Villaflor G, Tilley D, Shastri N, Grey H, Almo SC, Roopenian D, Nathenson SG. How H13 histocompatibility peptides differing by a single methyl group and lacking conventional MHC binding anchor motifs determine self-nonself discrimination. Journal of Immunology (Baltimore, Md. : 1950). 168: 283-9. PMID 11751972 DOI: 10.4049/Jimmunol.168.1.283 | 0.423 | |||
1998 | Kim CJ, Cormier J, Roden M, Gritz L, Mazzara GP, Fetsch P, Hijazi Y, Lee KH, Rosenberg SA, Marincola FM. Use of recombinant poxviruses to stimulate anti-melanoma T cell reactivity Annals of Surgical Oncology. 5: 64-76. PMID 9524710 DOI: 10.1007/Bf02303766 | 0.335 | |||
1997 | Kim CJ, Prevette T, Cormier J, Overwijk W, Roden M, Restifo NP, Rosenberg SA, Marincola FM. Dendritic cells infected with poxviruses encoding MART-1/Melan A sensitize T lymphocytes in vitro Journal of Immunotherapy. 20: 276-286. PMID 9220317 DOI: 10.1097/00002371-199707000-00004 | 0.325 | |||
Show low-probability matches. |